by Paul McIntosh | Jul 14, 2026 | 2026, In the News
NovaBiotics’ cysteamine pipeline continues to advance through its collaboration with the Liverpool School of Tropical Medicine (LSTM). Grant funding from the Medical Research Council has been secured to investigate how cysteamine can boost the immune...
by Paul McIntosh | Mar 24, 2025 | 2025, Press Releases
On world TB Day 2025, NovaBiotics Ltd (NovaBiotics) and Liverpool School of Tropical Medicine (LSTM) announce that they are working together to investigate the use of oral cysteamine bitartrate in the treatment of mycobacterial disease, including tuberculosis (TB)....
Recent Comments